LENZ Therapeutics, Inc. (LENZ)
4.59
-0.09
(-1.92%)
USD |
NASDAQ |
Aug 24, 16:00
4.60
+0.01
(+0.22%)
After-Hours: 20:00
LENZ Therapeutics Debt to Equity Ratio : 0.0026 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0026 |
| March 31, 2026 | 0.0027 |
| December 31, 2025 | 0.0029 |
| September 30, 2025 | 0.0049 |
| June 30, 2025 | 0.0051 |
| March 31, 2025 | 0.0062 |
| December 31, 2024 | 0.0068 |
| September 30, 2024 | 0.0073 |
| June 30, 2024 | 0.0088 |
| March 31, 2024 | 0.003 |
| December 31, 2023 | 0.0065 |
| September 30, 2023 | 0.2603 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.2389 |
| March 31, 2023 | 0.0164 |
| December 31, 2022 | 0.0196 |
| September 30, 2022 | 0.0221 |
| June 30, 2022 | 0.0242 |
| March 31, 2022 | 0.0282 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0237 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ocular Therapeutix, Inc. | 0.1526 |
| Enveric Biosciences, Inc. | 0.00 |
| Liquidia Corp. | 0.9374 |
| Aquestive Therapeutics, Inc. | -2.635 |
| Impact BioMedical, Inc. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 236.60M |
| Total Liabilities (Quarterly) | 17.33M |
| Shareholders Equity (Quarterly) | 219.26M |
| Current Ratio | 13.55 |
| Net Debt Paydown Yield | 0.07% |